The daily business briefing: July 15, 2020

Moderna coronavirus vaccine candidate shows promise in early trial, U.K. bars the use of Huawei 5G gear, and more 

Moderna headquarters
(Image credit: Getty Images)

1. Moderna reports 'robust' immune response in early coronavirus vaccine trial

Drugmaker Moderna said Tuesday that its potential coronavirus vaccine resulted in a "robust" immune response in the 45 patients participating in its early stage human trial. The patients, divided into groups of 15, received doses of 25, 100, or 250 micrograms of the drug, and after two vaccinations all of them had produced neutralizing antibodies, according to data published in the peer-reviewed New England Journal of Medicine. Moderna shares jumped by 16 percent in after-hour trading on the news. Other stocks particularly sensitive to the lifting of coronavirus lockdown measures, including American and United airlines, and Royal Caribbean Cruise all gained more than 4 percent. U.S. stock index futures also rose before the start of trading Wednesday.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.